WHO ICTRP trial

A prospective, randomized, parallel, blank controlled, open-label clinical study…

ChiCTR2500096189 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2500096189
Public title A prospective, randomized, parallel, blank controlled, open-label clinical study to evaluate the safety and efficacy of cord mesenchymal stem cells injected into the spinal cord for subacute traumatic spinal cord injury
Scientific title A prospective, randomized, parallel, blank controlled, open-label clinical study to evaluate the safety and efficacy of cord mesenchymal stem cells injected into the spinal cord for subacute traumatic spinal cord injury
Primary sponsor Xi 'an GaoXin Hospital
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Countries China
Conditions Traumatic subacute spinal cord injury
Interventions Transplantation group:Intraspinal injection of umbilical cord mesenchymal stem cells+Rehabilitation;Control group:Rehabilitation
Registration date Jan 20, 2025
Target size Transplantation group:10;Control group:10
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations